Abstract
This is the 2nd Symposium of a series organized annually. It aims to integrate tumor immunology basic research with results from most recent clinical trials based on the use of anti-cancer agents targeting immune system components.
http://ift.tt/2ki2wpm
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου